Similarity of polygenic profiles limits the potential for elite human physical performance

Journal of Physiology

Volumn 586, Issue 1, 2008, Pages 113-121

  Williams, Alun G ^a   Folland, Jonathan P ^b  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; ENDURANCE; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; PHENOTYPE; PHYSICAL CAPACITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; SPORT; CORRELATIONAL STUDY; MATHEMATICAL ANALYSIS; MULTIFACTORIAL INHERITANCE; POPULATION STATISTICS;

DNA FINGERPRINTING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; PHENOTYPE; PHYSICAL ENDURANCE; POLYMORPHISM, GENETIC;

EID: 37749047481     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.141887     Document Type: Article

References (42)

1. Ahmetov II, Mozhayskaya I, Flavell D, Astratenkova IV, Komkova AI, Lyubaeva EV, Tarakin P, Shenkman B, Vdovina A, Netreba AI, Popov DV, Vinogradova O, Montgomery H & Rogozkin V (2006). PPAR α gene variation and physical performance in Russian athletes. Eur J Appl Physiol 97, 103-108.
2. 2max response to exercise training: Results from the HERITAGE Family Study. J Appl Physiol 87, 1003-1008.
3. 2max in the sedentary state: The HERITAGE Family Study. Med Sci Sports Exerc 30, 252-258.
4. Bouchard C, Lesage R, Lortie G, Simoneau JA, Hamel P, Boulay MR, Perusse L, Theriault G & Leblanc C (1986). Aerobic performance in brothers, dizygotic and monozygotic twins. Med Sci Sports Exerc 18, 639-646.
5. Bramble DM & Lieberman DE (2004). Endurance running and the evolution of Homo. Nature 432, 345-352.
6. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni JF Jr, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ, Wacholder S, Wijsman EM, Winn DM & Collins FS (2007). Replicating genotype-phenotype associations. Nature 447, 655-660.
7. Chicharro JL, Hoyos J, Gomez-Gallego F, Villa JG, Bandres F, Celaya P, Jimenez F, Alonso JM, Cordova A & Lucia A (2004). Mutations in the hereditary haemochromatosis gene HFE in professional endurance athletes. Br J Sports Med 38, 418-421.
8. 2max, and response to endurance training. Med Sci Sports Exerc 23, 177-185.
9. Drenos F, Whittaker JC & Humphries SE (2007). The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk. Ann Hum Genet 71, 611-619.
10. Fagard R, Bielen E & Amery A (1991). Heritability of aerobic power and anaerobic energy generation during exercise. J Appl Physiol 70, 357-362.
11. Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS & Trent RJ (1998). Elite endurance athletes and the ACE I allele -the role of genes in athletic performance. Hum Genet 103, 48-50.
12. Hagberg JM, Ferrell RE, Katzel LI, Dengel DR, Sorkin JD & Goldberg AP (1999). Apolipoprotein E genotype and exercise training-induced increases in plasma high-density lipoprotein (HDL)- and HDL2-cholesterol levels in overweight men. Metabolism 48, 943-945.
13. Henderson J, Withford-Cave JM, Duffy DL, Cole SJ, Sawyer NA, Gulbin JP, Hahn A, Trent RJ & Yu B (2005). The EPAS1 gene influences the aerobic-anaerobic contribution in elite endurance athletes. Hum Genet 118, 416-423.
14. Jones AM & Carter H (2000). The effect of endurance training on parameters of aerobic fitness. Sports Med 29, 373-386.
15. Joyner MJ (1991). Modeling: Optimal marathon performance on the basis of physiological factors. J Appl Physiol 70, 683-687.
16. Klissouras V (1971). Heritability of adaptive variation. J Appl Physiol 31, 338-344.
17. Kyle CV, Abbott W, Young RP, Nijmeijer B, Simmons D & Braatvedt GD (2001). Angiotensin-1-converting enzyme and angiotensinogen gene polymorphisms in Maori and Pacific Island people in New Zealand. Intern Med J 31, 116-118.
18. Lee CD, Blair SN & Jackson AS (1999). Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr 69, 373-380.
19. Lieberman DE, Raichlen DA, Pontzer H, Bramble DM & Cutright-Smith E (2006). The human gluteus maximus and its role in running. J Exp Biol 209, 2143-2155.
20. Lucia A, Gomez-Gallego F, Barroso I, Rabadan M, Bandres F, San Juan AF, Chicharro JL, Ekelund U, Brage S, Earnest CP, Wareham NJ & Franks PW (2005). PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl Physiol 99, 344-348.
21. Lucia A, Gomez-Gallego F, Santiago C, Bandres F, Earnest C, Rabadan M, Alonso JM, Hoyos J, Cordova A, Villa G & Foster C (2006). ACTN3 genotype in professional endurance cyclists. Int J Sports Med 27, 880-884.
22. Mastana S, Lee D, Singh PP & Singh M (2003). Molecular genetic variation in the East Midlands, England: Analysis of VNTR, STR and Alu insertion/deletion polymorphisms. Ann Hum Biol 30, 538-550.
23. Moore GE, Shuldiner AR, Zmuda JM, Ferrell RE, McCole SD & Hagberg JM (2001). Obesity gene variant and elite endurance performance. Metabolism 50, 1391-1392.
24. Moran CN, Yang N, Bailey ME, Tsiokanos A, Jamurtas A, Macarthur DG, North K, Pitsiladis YP & Wilson RH (2007). Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur J Hum Genet 15, 88-93.
25. Niemi AK & Majamaa K (2005). Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 13, 965-969.
26. Ortlepp JR, Metrikat J, Vesper K, Mevissen V, Schmitz F, Albrecht M, Maya-Pelzer P, Hanrath P, Weber C, Zerres K & Hoffmann R (2003). The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers. J Mol Med 81, 578-584.
27. Paparini A, Ripani M, Giordano GD, Santoni D, Pigozzi F & Romano-Spica V (2007). ACTN3 genotyping by real-time PCR in the Italian population and athletes. Med Sci Sports Exerc 39, 810-815.
28. Pitsiladis YP & Scott R (2005). Essay: The makings of the perfect athlete. Lancet 366 (Suppl. 1), S16-S17.
29. Rankinen T, Bray MS, Hagberg JM, Perusse L, Roth SM, Wolfarth B & Bouchard C (2006 a). The human gene map for performance and health-related fitness phenotypes: The 2005 update. Med Sci Sports Exerc 38, 1863-1888.
30. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Perusse L & Bouchard C (2006b). The human obesity gene map: The 2005 update. Obesity 14, 529-644.
31. Rico-Sanz J, Rankinen T, Joanisse DR, Leon AS, Skinner JS, Wilmore JH, Rao DC & Bouchard C (2003). Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study. Physiol Genomics 14, 161-166.
32. Rubio JC, Martin MA, Rabadan M, Gomez-Gallego F, San Juan AF, Alonso JM, Chicharro JL, Perez M, Arenas J & Lucia A (2005). Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: Does this mutation impair performance? J Appl Physiol 98, 2108-2112.
33. Schessl J, Zou Y & Bonnemann CG (2006). Congenital muscular dystrophies and the extracellular matrix. Semin Pediatr Neurol 13, 80-89.
34. Sharp NCC (2004). Mind the gap: Women racers are falling behind. Nature 432, 147.
35. Spurway N (2006). Top-down studies of genetic contribution to differences in physical capacity. In Genetics and Molecular Biology of Muscle Adaptation, ed. Spurway N & Wackerhage H, pp. 25-59. Churchill Livingstone, Elsevier, London.
36. Tarnopolsky MA & Raha S (2005). Mitochondrial myopathies: Diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc 37, 2086-2093.
37. Thompson PD, Tsongalis GJ, Seip RL, Bilbie C, Miles M, Zoeller R, Visich P, Gordon P, Angelopoulos TJ, Pescatello L, Bausserman L & Moyna N (2004). Apolipoprotein E genotype and changes in serum lipids and maximal oxygen uptake with exercise training. Metabolism 53, 193-202.
38. Williams AG, Dhamrait SS, Wootton PTE, Day SH, Hawe E, Payne JR, Myerson SG, World M, Budgett R, Humphries SE & Montgomery HE (2004). Bradykinin receptor gene variant and human physical performance. J Appl Physiol 96, 938-942.
39. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE & Montgomery HE (2000). The ACE gene and muscle performance. Nature 403, 614.
40. Wolfarth B, Rivera MA, Oppert JM, Boulay MR, Dionne FT, Chagnon M, Gagnon J, Chagnon Y, Perusse L, Keul J & Bouchard C (2000). A polymorphism in the alpha2A-adrenoceptor gene and endurance athlete status. Med Sci Sports Exerc 32, 1709-1712.
41. Yang Q, Khoury MJ, Friedman J, Little J & Flanders WD (2005). How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 34, 1129-1137.
42. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S & North K (2003). ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 73, 627-631.